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We report the development of a new ultrasensitive approach for label-free DNA detection using 
magnetic nanoparticle (MNP)-assisted rapid target capture/separation in combination with signal 
amplification using poly-enzyme tagged polymer nanobead. The sensor uses a MNP linked capture 
DNA and a biotin modified signal DNA to sandwich bind the target followed by ligation to provide 
high single-nucleotide polymorphism discrimination. Only the presence of a perfect match target 
DNA yields a covalent linkage between the capture and signal DNAs for subsequent binding to a 
neutravidin-modified horseradish peroxidase (HRP) enzyme via the strong biotin–neutravidin 
interaction. This converts each captured full match DNA target into a HRP which can convert 
millions of copies of a non-fluorescent substrate (amplex red) to a highly fluorescent product 
(resorufin) for great signal amplification. The use of polymer nanobead each tagged with thousands 
of copies of HRPs as the signal amplifier greatly improves the signal amplification power, leading to 
greatly improved sensitivity. This biosensing approach can specifically detect an unlabelled DNA 
target down to 10 aM with a wide dynamic range of 5 orders of magnitude (from 0.01 fM to 1000 fM). 
Furthermore, our approach has a high discrimination between a perfectly matched gene and its 
cancer-related single-base mismatch targets (SNPs): it can positively detect the perfect match DNA 
target even in the presence of 100-fold excess of co-existing SNPs. This sensing approach also works 
robustly in clinical relevant media (e.g., 10% human serum) and gives almost the same SNP 
discrimination ratio as that in clean buffers. Therefore, this ultrasensitive SNP biosensor appears to 
be well-suited for potential diagnostic applications of genetic diseases. 
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